The month of June is set to be a crucial period for Unicycive Therapeutics Inc. (UNCY), as it stands on the threshold of a key regulatory event that could significantly shape its near-term prospects.
The FDA decision on the company's lead drug candidate, Oxylanthanum Carbonate, or OLC in short, proposed for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis, is due on June 29, 2026.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.